Stock Groups

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.48% By Investing.com

[ad_1]

© Reuters U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.48%

Investing.com – U.S. stocks were lower after the close on Friday, as losses in the , and sectors led shares lower.

At the close in NYSE, the lost 0.48%, while the index fell 0.91%, and the index declined 0.91%.

The best performers of the session on the were Amgen Inc (NASDAQ:), which rose 0.93% or 2.02 points to trade at 219.38 at the close. Meanwhile, UnitedHealth Group Incorporated (NYSE:) added 0.80% or 3.32 points to end at 420.16 and American Express Company (NYSE:) was up 0.79% or 1.29 points to 163.92 in late trade.

Dow Inc (NYSE 🙂 fell 2.9% or 1.72 to trade at 56.75 at close. Caterpillar Inc (NYSE:) declined 1.89% or 3.85 points to end at 199.75 and Apple Inc (NASDAQ:) was down 1.83% or 2.73 points to 146.06.

The top performers on the S&P 500 were Thermo Fisher Scientific Inc (NYSE:) which rose 6.49% to 596.80, Invesco Plc (NYSE:) which was up 5.46% to settle at 26.25 and Centene Corp (NYSE:) which gained 4.95% to close at 64.64.

The worst performers were Unum Group (NYSE:) which was down 6.04% to 24.27 in late trade, International Flavors & Fragrances Inc (NYSE:) which lost 5.53% to settle at 135.21 and Copart Inc (NASDAQ:) which was down 5.46% to 143.95 at the close.

The top performers on the NASDAQ Composite were Corvus Pharmaceuticals Inc (NASDAQ:) which rose 135.40% to 5.320, Helbiz Inc (NASDAQ:) which was up 96.56% to settle at 17.69 and Priority Technology Holdings Inc (NASDAQ:) which gained 47.23% to close at 7.450.

The worst performers were Protagonist Therapeutics Inc (NASDAQ:) which was down 62.00% to 17.53 in late trade, Tcr2 Therapeutics Inc (NASDAQ:) which lost 36.45% to settle at 9.99 and Eliem Therapeutics Inc (NASDAQ:) which was down 21.92% to 18.77 at the close.

The New York Stock Exchange saw falling stocks surpassing advancing stock by 2032, 1163 to 17.53, 135 was unchanged, and Tcr2 Therapeutics Inc (NASDAQ) lost 36.45% to settle at 9.99. On the Nasdaq Stock Exchange 1901 rose, 1681 fell, while 154 was unchanged.

Thermo Fisher Scientific Inc. (NYSE:), shares rose to new highs, gaining 6.9% or 36.36 to 566.68.80. Corvus Pharmaceuticals Inc. shares (NASDAQ:) reached 52-week peak; an increase of 135.40%, or 3.060 to 5.320. Protagonist Therapeutics Inc. (NASDAQ:), shares fell to 52 week lows, down 62.00%. This is a decrease of 28.60 to 17.53. Helbiz Inc’s shares (NASDAQ:), rose to their highest levels ever, rising 96.56% to 8.69 to 17.69. Tcr2 Therapeutics Inc shares (NASDAQ:) dropped to 52 week lows, falling 36.45% (5.73 to 9.99).

The , which measures the implied volatility of S&P 500 options, was up 11.34% to 20.81.

The December delivery of Gold Futures was lower by 0.24%, or 4.15 to $1752.55 per troy ounce. In commodities trading, crude oil fell 0.64 or 0.88% to $71.92 per barrel in October. The November Brent oil contract dropped 0.36 or 0.48% to $75.31 per barrel.

EUR/USD fell 0.31% at 1.1728 while USD/JPY rose 0.2% to 109.98.

US Dollar Index Futures were up 0.3% at 93.213.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. CFDs include futures, stocks, indexes and Forex. Prices are provided not by the exchanges. They are provided by market makers. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses you may incur due to the use of these data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.



[ad_2]